Navigation Links
ThermoGenesis Announces FDA Authorization to Market MarrowXpress(TM) (MXP(TM))
Date:7/14/2008

se actual outcomes to differ materially from those contemplated by the forward-looking statements. Several factors, including timing of FDA approvals, changes in customer forecasts, our failure to meet customers' purchase order and quality requirements, supply shortages, production delays, changes in the markets for customers' products, introduction timing and acceptance of our new products scheduled for fiscal year 2009, and introduction of competitive products and other factors beyond our control, could result in a materially different revenue outcome and/or in our failure to achieve the revenue levels we expect for fiscal 2009. A more complete description of these and other risks that could cause actual events to differ from the outcomes predicted by our forward-looking statements is set forth under the caption "Risk Factors" in our annual report on Form 10-K and other reports we file with the Securities and Exchange Commission from time to time, and you should consider each of those factors when evaluating the forward-looking statements.

ThermoGenesis Corp.

Web site: http://www.thermogenesis.com

Contact: Investor Relations

+1-916-858-5107, or

ir@thermogenesis.com


'/>"/>
SOURCE ThermoGenesis Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. ThermoGenesis Announces Receipt of CE Mark for MarrowXpress(TM)
2. ThermoGenesis Names Dr. Mahendra Rao to Board of Directors
3. ThermoGenesis Subsidiary Vantus Announces Stem Cell Agreement With UC Davis Center For Equine Health
4. ThermoGenesis Corp. Announces Voluntary Recall of Selected Lots of AXP Bag Sets
5. ThermoGenesis Corp. Reports 48 Percent Growth in Second Quarter Revenues Year Over Year
6. ThermoGenesis Corp. to Announce Second Quarter Fiscal 2008 Results on February 6, 2008
7. ThermoGenesis Corp. to Announce First Quarter Fiscal 2008 Results on November 8, 2007
8. ThermoGenesis Corp. to Present at 2007 Global Life Sciences Conference on Thursday, September 27, 2007
9. ThermoGenesis Corp. Reports Fourth Quarter and Fiscal Year 2007 Results
10. ThermoGenesis Corp. to Announce Fourth Quarter and Year End Results for Fiscal Year 2007 on September 12, 2007
11. NuVasive Announces Web Cast and Conference Call of Second Quarter 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... 26, 2015 WORMS, GERMANY – ... Co. (NYSE: GRA) announces that its manufacturing facility ... (GMP) certification from EXCiPACT™, an independent organization that ... , All three Grace facilities that ... excipient silica gels have now received GMP certification, ...
(Date:5/26/2015)... , Kalifornien und HILDEN, Deutschland, May ... QIAGEN Clinical Insight ® ... Genvarianten und die Erstellung dazugehöriger Berichte; Vorstellung ...     QIAGEN N.V. (NASDAQ: ... heute die Markteinführung von QIAGEN Clinical Insight ...
(Date:5/26/2015)... 2015  Sangamo BioSciences, Inc. (NASDAQ: SGMO ) announced ... will provide an update on the progress of Sangamo,s ZFP ... company,s business strategy at 1:30pm ET on Monday, June 1, ... is being held in New York, NY ... may be accessed via a link on the Sangamo BioSciences ...
(Date:5/26/2015)... , May 26, 2015  Alere Inc. (NYSE: ALR ... its failure to timely file its Quarterly Report on Form ... "Form 10-Q"), it has received a notice from the New ... in compliance with the NYSE,s continued listing requirements under the ... Listed Company Manual. The reason for the ...
Breaking Biology Technology:CORRECTION: Grace European Facility Receives GMP Excipient Certification for SYLOID® FP Silica Gel 2QIAGEN bringt klinische Bioinformatik-Plattform für Next Generation Sequencing-Anwendungen auf den Markt 2QIAGEN bringt klinische Bioinformatik-Plattform für Next Generation Sequencing-Anwendungen auf den Markt 3QIAGEN bringt klinische Bioinformatik-Plattform für Next Generation Sequencing-Anwendungen auf den Markt 4QIAGEN bringt klinische Bioinformatik-Plattform für Next Generation Sequencing-Anwendungen auf den Markt 5QIAGEN bringt klinische Bioinformatik-Plattform für Next Generation Sequencing-Anwendungen auf den Markt 6Sangamo BioSciences Announces Presentation At The Jefferies 2015 Global Healthcare Conference 2
... , NEW HAVEN, Conn., Sept. ... discovery, development and commercialization of novel drugs for the treatment ... been appointed to the Company,s Board of Directors, succeeding Joseph ... Zook is President of MedImmune, Chief Executive Officer of AstraZeneca ...
... , CHENGDU, China, Sept. ... TPI ), a manufacturer and supplier ... its new,production facility obtained the Good Manufacturing Practices ... Food and Drug,Administration ("SFDA") in China. , ...
... VIENNA, Va., Sept. 16 CEL-SCI Corporation ... and therapeutics for the prevention and treatment of infectious diseases ... Food and Drug Administration (FDA) has indicated that the Company ... effect of its investigational LEAPS-H1N1 treatment on the white blood ...
Cached Biology Technology:Rib-X Pharmaceuticals, Inc. Appoints Tony Zook of MedImmune to Board of Directors 2Rib-X Pharmaceuticals, Inc. Appoints Tony Zook of MedImmune to Board of Directors 3Tianyin Pharmaceutical Co., Inc. Obtains GMP Certification for Its New Production Facility 2Tianyin Pharmaceutical Co., Inc. Obtains GMP Certification for Its New Production Facility 3CEL-SCI to Commence First Clinical Study with Hospitalized H1N1 Infected Patients 2CEL-SCI to Commence First Clinical Study with Hospitalized H1N1 Infected Patients 3CEL-SCI to Commence First Clinical Study with Hospitalized H1N1 Infected Patients 4
(Date:4/21/2015)... 2015 High crime rate, ... boosting access control systems market in Saudi ... recently published report by TechSci Research " Saudi Arabia Access ... control systems market in Saudi Arabia ... access control systems market in the Kingdom is growing ...
(Date:4/17/2015)... 2015 Increasing adoption ... advancement to drive biometric systems market in ... According to a recently released TechSci ... ", biometric systems market in Saudi ... at CAGR of over 22% through 2020. The ...
(Date:4/13/2015)... 13, 2015 According to ... Biometrics Market Forecast & Opportunities, 2020", the global biometrics ... around 14% till 2020. The biometrics market is ... implementation and review of biometric management systems. The ... products with greater efficiency, are resulting in increasing ...
Breaking Biology News(10 mins):Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 2Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 3Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 2Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 3Global Biometrics Market to Cross US$ 21 Billion by 2020: TechSci Research 2
... from the ARC Centre of Excellence for Coral Reef ... science to help solve some of the world,s biggest ... science fellow at the ARC CoECRS, holds a joint ... University in the USA. Dr Hicks says more ...
... WEST LAFAYETTE, Ind. Researchers have discovered a tube-shaped structure ... deliver its DNA during the infection process and then dissolves ... mechanism in the phiX174 virus, which attacks E. coli ... bacteria, is in a class of viruses that do not ...
... by scientists could help combat the spread of sleeping sickness. ... to communicate with one another could help limit the spread of ... could be designed to disrupt the flow of messages sent between ... disrupts sleep patterns is transmitted by the bite of the ...
Cached Biology News:Linking social science and ecology to solve the world's environmental problems 2Virus grows tube to insert DNA during infection then sheds it 2
Guanine nucleotide-binding protein G(k), alpha subunit...
Goat anti-VAV2 Class: Antibody Product Group: Miscellaneous Antibody...
... P7 D7 F5] to RYK ( ... Antigen: Synthetic ... to amino acids 462 - 475 ... Gene ID: 6259 ...
DAP12 Market Segment: Protein Kinases...
Biology Products: